210 related articles for article (PubMed ID: 33393175)
1. Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.
Hyodo M; Nagao A; Asano K; Sakaguchi M; Mizoguchi K; Omori K; Tada Y; Hatakeyama H; Oridate N; Naito K; Iwata Y; Shinomiya H; Hara H; Sanuki T; Yumoto E
Eur J Neurol; 2021 May; 28(5):1548-1556. PubMed ID: 33393175
[TBL] [Abstract][Full Text] [Related]
2. Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.
Hirose K; Asano K; Sakaguchi M; Nagao A; Nakahira M; Doi N; Kobayashi T; Hyodo M
Laryngoscope Investig Otolaryngol; 2021 Oct; 6(5):1088-1095. PubMed ID: 34667852
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update.
Hyodo M; Hirose K; Nagao A; Nakahira M; Kobayashi T
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878189
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis.
Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P
J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.
Hyodo M; Asano K; Nagao A; Hirose K; Nakahira M; Yanagida S; Nishizawa N
Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941678
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
7. [Treatment efficacy of electronic endoscope-guided botulinum toxin injection in adductor spasmodic dysphonia patients].
Ren J; Yang H; Wang H; Zou J; Lv D; Yu L; Zheng Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 34(11):1019-1023. PubMed ID: 33254323
[No Abstract] [Full Text] [Related]
8. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia.
Sanuki T; Takemoto N
Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482
[TBL] [Abstract][Full Text] [Related]
9. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.
Kim JW; Park JH; Park KN; Lee SW
ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort.
French G; Bosch JD; Randall DR
J Otolaryngol Head Neck Surg; 2020 Jan; 49(1):4. PubMed ID: 31937363
[TBL] [Abstract][Full Text] [Related]
11. Neurectomy and Myomectomy for Treatment of Spasmodic Dysphonia.
Ryan W; Alnouri G; Sataloff RT
J Voice; 2024 Jan; 38(1):239-242. PubMed ID: 35738960
[TBL] [Abstract][Full Text] [Related]
12. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance.
Kunieda C; Nin F; Ohashi T; Hosokawa K; Watanabe Y; Ogawa T; Mori T; Kanazawa T
Auris Nasus Larynx; 2024 Apr; 51(2):361-364. PubMed ID: 37838568
[TBL] [Abstract][Full Text] [Related]
14. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; Badía PI; Lagos-Villaseca A
Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
Morzaria S; Damrose EJ
J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
[TBL] [Abstract][Full Text] [Related]
16. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
[TBL] [Abstract][Full Text] [Related]
17. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
18. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
van Esch BF; Wegner I; Stegeman I; Grolman W
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
20. [Spasmodic Dysphonia].
Tokashiki R
Brain Nerve; 2023 Jan; 75(1):15-22. PubMed ID: 36574969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
